Výsledky vyhledávání - Rinath Jeselsohn

Upřesnit hledání
  1. 1
    ESR1 fusions and therapeutic resistance in metastatic breast cancer

    ESR1 fusions and therapeutic resistance in metastatic breast cancer Autor Zsuzsanna Nagy, Rinath Jeselsohn

    Vydáno 2023
    Získat plný text Získat plný text
    Revisão
    Přidat do oblíbených
    Uloženo v:
  2. 2
    PROteolysis TArgeting Chimera (PROTAC) Estrogen Receptor Degraders for Treatment of Estrogen Receptor–Positive Advanced Breast Cancer

    PROteolysis TArgeting Chimera (PROTAC) Estrogen Receptor Degraders for Treatment of Estrogen Receptor–Positive Advanced Breast Cancer Autor Erika Hamilton, Rinath Jeselsohn, Linda T. Vahdat, Sara A. Hurvitz

    Vydáno 2025
    Získat plný text
    Revisão
    Přidat do oblíbených
    Uloženo v:
  3. 3
    Oral Selective Estrogen Receptor Degraders (SERDs) in Breast Cancer: Advances, Challenges, and Current Status

    Oral Selective Estrogen Receptor Degraders (SERDs) in Breast Cancer: Advances, Challenges, and Current Status Autor Teesha Downton, Fiona H. Zhou, Davendra Segara, Rinath Jeselsohn, Elgene Lim

    Vydáno 2022
    Získat plný text Získat plný text
    Revisão
    Přidat do oblíbených
    Uloženo v:
  4. 4
    ESR1 mutations—a mechanism for acquired endocrine resistance in breast cancer

    ESR1 mutations—a mechanism for acquired endocrine resistance in breast cancer Autor Rinath Jeselsohn, Gilles Buchwalter, Carmine De Angelis, Myles Brown, Rachel Schiff

    Vydáno 2015
    Získat plný text
    Revisão
    Přidat do oblíbených
    Uloženo v:
  5. 5
    ESR1 activating mutations: From structure to clinical application

    ESR1 activating mutations: From structure to clinical application Autor Albert Grinshpun, Vincent Chen, Zachary M. Sandusky, Sean W. Fanning, Rinath Jeselsohn

    Vydáno 2022
    Získat plný text
    Revisão
    Přidat do oblíbených
    Uloženo v:
  6. 6
    The dilemma of selecting a first line CDK4/6 inhibitor for hormone receptor-positive/HER2-negative metastatic breast cancer

    The dilemma of selecting a first line CDK4/6 inhibitor for hormone receptor-positive/HER2-negative metastatic breast cancer Autor Albert Grinshpun, Sara M. Tolaney, Harold J. Burstein, Rinath Jeselsohn, Erica L. Mayer

    Vydáno 2023
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  7. 7
    Cyclin D1 Activity Regulates Autophagy and Senescence in the Mammary Epithelium

    Cyclin D1 Activity Regulates Autophagy and Senescence in the Mammary Epithelium Autor Nelson E. Brown, Rinath Jeselsohn, Teeru Bihani, Miaofen G. Hu, Parthena Foltopoulou, Charlotte Kuperwasser, Philip W. Hinds

    Vydáno 2012
    Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  8. 8
    Cyclin D1 Kinase Activity Is Required for the Self-Renewal of Mammary Stem and Progenitor Cells that Are Targets of MMTV-ErbB2 Tumorigenesis

    Cyclin D1 Kinase Activity Is Required for the Self-Renewal of Mammary Stem and Progenitor Cells that Are Targets of MMTV-ErbB2 Tumorigenesis Autor Rinath Jeselsohn, Nelson E. Brown, Lisa M. Arendt, Ina Klebba, Miaofen G. Hu, Charlotte Kuperwasser, Philip W. Hinds

    Vydáno 2010
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  9. 9
    Mixed Invasive Ductal and Lobular Carcinoma of the Breast: Prognosis and the Importance of Histologic Grade

    Mixed Invasive Ductal and Lobular Carcinoma of the Breast: Prognosis and the Importance of Histologic Grade Autor Otto Metzger, Arlindo R. Ferreira, Rinath Jeselsohn, William T. Barry, Deborah Dillon, Jane E. Brock, Inês Vaz-Luís, Melissa E. Hughes, Eric P. Winer, Nancy U. Lin

    Vydáno 2018
    Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  10. 10
    Phase Ib SEASTAR Study: Combining Rucaparib and Sacituzumab Govitecan in Patients With Cancer With or Without Mutations in Homologous Recombination Repair Genes

    Phase Ib SEASTAR Study: Combining Rucaparib and Sacituzumab Govitecan in Patients With Cancer With or Without Mutations in Homologous Recombination Repair Genes Autor Timothy A. Yap, Erika Hamilton, Todd M. Bauer, Ecaterina E. Dumbrava, Rinath Jeselsohn, Aaron Enke, Sabrina Hurley, Kevin K. Lin, Jenn Habeck, Heidi Giordano, Geoffrey I. Shapiro

    Vydáno 2022
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  11. 11
    PDEF Promotes Luminal Differentiation and Acts as a Survival Factor for ER-Positive Breast Cancer Cells

    PDEF Promotes Luminal Differentiation and Acts as a Survival Factor for ER-Positive Breast Cancer Cells Autor Gilles Buchwalter, Michele M. Hickey, Anne Cromer, Laura M. Selfors, Ruwanthi N. Gunawardane, Jason Frishman, Rinath Jeselsohn, Elgene Lim, David Chi, Xiaoyong Fu, Rachel Schiff, Myles Brown, Joan S. Brugge

    Vydáno 2013
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  12. 12
    Combined inhibition of KAT6A/B and Menin reverses estrogen receptor-driven gene expression programs in breast cancer

    Combined inhibition of KAT6A/B and Menin reverses estrogen receptor-driven gene expression programs in breast cancer Autor Sarah Naomi Olsen, Bryn Anderson, Charlie Hatton, Zhengtao Chu, Christopher E. Simpkins, Yanhe Wen, Wallace Bourgeois, Elena Haarer, Myles Brown, Rinath Jeselsohn, Alana L. Welm, Eneda Toska, Scott A. Armstrong

    Vydáno 2025
    Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  13. 13
    Estrogen receptor signaling is reprogrammed during breast tumorigenesis

    Estrogen receptor signaling is reprogrammed during breast tumorigenesis Autor David Chi, Hari Singhal, Lewyn Li, Tengfei Xiao, Weihan Liu, Matthew Pun, Rinath Jeselsohn, Housheng He, Elgene Lim, Raga Vadhi, Prakash K. Rao, Henry W. Long, Judy E. Garber, Myles Brown

    Vydáno 2019
    Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  14. 14
    D538G Mutation in Estrogen Receptor-α: A Novel Mechanism for Acquired Endocrine Resistance in Breast Cancer

    D538G Mutation in Estrogen Receptor-α: A Novel Mechanism for Acquired Endocrine Resistance in Breast Cancer Autor Keren Merenbakh-Lamin, Noa Ben-Baruch, Adva Yeheskel, Addie Dvir, Lior Soussan‐Gutman, Rinath Jeselsohn, Roman Yelensky, Myles Brown, Vincent A. Miller, David Sarid, Shulamith Rizel, Baruch Klein, Tamar Rubinek, Ido Wolf

    Vydáno 2013
    Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  15. 15
    CoBRA: Containerized Bioinformatics Workflow for Reproducible ChIP/ATAC-Seq Analysis

    CoBRA: Containerized Bioinformatics Workflow for Reproducible ChIP/ATAC-Seq Analysis Autor Xintao Qiu, Avery Feit, Ariel Feiglin, Yingtian Xie, Nikolas Kesten, Len Taing, Joseph Perkins, Shengqing Gu, Yihao Li, Paloma Cejas, Ningxuan Zhou, Rinath Jeselsohn, Myles Brown, X. Shirley Liu, Henry W. Long

    Vydáno 2021
    Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  16. 16
    VIPER: Visualization Pipeline for RNA-seq, a Snakemake workflow for efficient and complete RNA-seq analysis

    VIPER: Visualization Pipeline for RNA-seq, a Snakemake workflow for efficient and complete RNA-seq analysis Autor MacIntosh Cornwell, Mahesh Vangala, Len Taing, Zachary T. Herbert, Johannes Köster, Bo Li, Hanfei Sun, Taiwen Li, Jian Zhang, Xintao Qiu, Matthew Pun, Rinath Jeselsohn, Myles Brown, X. Shirley Liu, Henry W. Long

    Vydáno 2018
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  17. 17
    Prognostic and Biologic Significance of ERBB2-Low Expression in Early-Stage Breast Cancer

    Prognostic and Biologic Significance of ERBB2-Low Expression in Early-Stage Breast Cancer Autor Paolo Tarantino, Qingchun Jin, Nabihah Tayob, Rinath Jeselsohn, Stuart J. Schnitt, Julie Vincuilla, Tonia Parker, Svitlana Tyekucheva, Tianyu Li, Nancy U. Lin, Melissa E. Hughes, Anna Weiss, Tari A. King, Elizabeth A. Mittendorf, Giuseppe Curigliano, Sara M. Tolaney

    Vydáno 2022
    Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  18. 18
    Estrogen Receptor Mutations as Novel Targets for Immunotherapy in Metastatic Estrogen Receptor–positive Breast Cancer

    Estrogen Receptor Mutations as Novel Targets for Immunotherapy in Metastatic Estrogen Receptor–positive Breast Cancer Autor Jonathan Goldberg, Na Qiao, Jennifer L. Guerriero, Brett Gross, Yagiz Meneksedag, Yoshimi F. Lu, Anne V. Philips, Tasnim Rahman, Funda Meric‐Bernstam, Jason Roszik, Ken Chen, Rinath Jeselsohn, Sara M. Tolaney, George E. Peoples, Gheath Alatrash, Elizabeth A. Mittendorf

    Vydáno 2024
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  19. 19
    Temporal and spatial topography of cell proliferation in cancer

    Temporal and spatial topography of cell proliferation in cancer Autor Giorgio Gaglia, Sheheryar Kabraji, Danae Rammos, Yang Dai, Ana Verma, Shu Wang, Caitlin E. Mills, Mirra Chung, Johann S. Bergholz, Shannon Coy, Jia‐Ren Lin, Rinath Jeselsohn, Otto Metzger, Eric P. Winer, Deborah Dillon, Jean J. Zhao, Peter K. Sorger, Sandro Santagata

    Vydáno 2022
    Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  20. 20
    Unraveling the clinicopathological features driving the emergence of ESR1 mutations in metastatic breast cancer

    Unraveling the clinicopathological features driving the emergence of ESR1 mutations in metastatic breast cancer Autor Yanan Kuang, Bilal A. Siddiqui, Jiani Hu, Matthew Pun, MacIntosh Cornwell, Gilles Buchwalter, Melissa E. Hughes, Nikhil Wagle, Paul Kirschmeier, Pasi A. Jänne, Cloud P. Paweletz, Nancy U. Lin, Ian E. Krop, William T. Barry, Eric P. Winer, Myles Brown, Rinath Jeselsohn

    Vydáno 2018
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:

Vyhledávací nástroje: